Back to search

Lovastatin Induces Fibroblast ApoptosisIn Vitro and In Vivo

Data up to Jan 2025

Published1999
Citations101
References47

Total Citations Per Year

Abstract

References (47)

Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation

1995 • 4,589 citations

Induction of apoptosis in fibroblasts by c-myc protein

1992 • 2,977 citations

Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.

1995 • 1,167 citations

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

1997 • 1,162 citations

Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF

1991 • 1,081 citations

Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

1991 • 861 citations

The Adult Respiratory Distress Syndrome

1971 • 774 citations

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

1992 • 665 citations

The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells

1994 • 647 citations

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1994 • 523 citations

Posttranslational modification of proteins by isoprenoids in mammalian cells

1990 • 515 citations

Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing.

1987 • 450 citations

Cell cycle-specific effects of lovastatin.

1991 • 301 citations

The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage.

1987 • 297 citations

Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis

1994 • 292 citations

A cell cycle-regulated inhibitor of cyclin-dependent kinases.

1994 • 285 citations

Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers.

1987 • 239 citations

Role of mesenchymal cell death in lung remodeling after injury.

1993 • 211 citations

Cell cycle-specific effects of tumor necrosis factor.

1984 • 204 citations

Lovastatin Induces Growth Inhibition and Apoptosis in Human Malignant Glioma Cells

1994 • 182 citations

The Reversal of an Adriamycin® Induced Healing Impairment with Chemoattractants and Growth Factors

1986 • 175 citations

Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis.

1990 • 173 citations

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

1998 • 173 citations

Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors

1996 • 168 citations

Translational Control of Programmed Cell Death: Eukaryotic Translation Initiation Factor 4E Blocks Apoptosis in Growth-Factor-Restricted Fibroblasts with Physiologically Expressed or Deregulated Myc

1996 • 164 citations

Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells.

1995 • 151 citations

Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 Cells

1994 • 144 citations

Differential Effects of Monoterpenes and Lovastatin on RAS Processing

1995 • 105 citations

Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells

1998 • 104 citations

Lovastatin-Induced Apoptosis in Prostate Stromal Cells

1997 • 90 citations

Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells

1996 • 90 citations

Cholesterol and mevalonic acid modulation in cell metabolism and multiplication

1992 • 87 citations

Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease.

1996 • 77 citations

Physiological Disposition of Hmg-Coa-Reductase Inhibitors

1990 • 68 citations

Fibroproliferative Disorders

1991 • 58 citations

Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype.

1992 • 55 citations

Inhibition of growth factor signaling pathways by lovastatin

1991 • 51 citations

Lovastatin Disrupts Early Events in Insulin Signaling: A Potential Mechanism of Lovastatins Anti-Mitogenic Activity

1994 • 49 citations

Potential Therapeutic Initiatives for Fibrogenic Lung Diseases

1995 • 47 citations

Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2.

1996 • 41 citations

Inhibition of Proliferative Activity of Pulmonary Fibroblasts by Tetrandrine

1993 • 36 citations

Lovastatin-Induced Apoptosis in Prostate Stromal Cells

1997 • 17 citations

Quantitative image analysis of angiogenesis in rats implanted with a fibrin gel chamber.

1992 • 17 citations

Mevalonate dependency of the early cell cycle mitogenic response to epidermal growth factor and prostaglandin F2α in Swiss mouse 3T3 cells

1995 • 14 citations

Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis.

1997 • 14 citations

Lovastatin induces apoptosis in a metastatic ovarian tumour cell line.

1996 • 12 citations

Mevalonate modulation of cell proliferation and apoptosis

1997 • 4 citations

Cited By (0)

Loading...
Lovastatin Induces Fibroblast ApoptosisIn Vitro and In Vivo (1999) – American Journal of Respiratory and Critical Care Medicine | Metascience Observatory Explorer